According to a team of researchers would be able to add to the list of breast cancer, apparently because fish oil supplementation would be associated with treatment of this disease. According to experts these supplements protect the body by reducing the inflammatory response itself.

For their study worked with 35 016 women between 50 and 76 years of age, who were interviewed in relation to their use of supplements of fish oil. The results revealed that those women who consumed more often had a lower risk of breast cancer.

One interesting thing to note is that omega-3 fatty acids have been highlighted on many occasions as being useful for treating diseases such as asthma, irritable bowel syndrome, diabetes and rheumatoid arthritis, so we see that the number of diseases preventable by omega 3 is considerable.

Sometimes after a lumpectomy, radiation therapy is internal rather than external. Internal radiation therapy involves the application of radioactive material contained in a thin metal wires or tubes that are implanted within the breast during a minor operation. These implants are then removed after a short period of time without leaving any other radioactive material. This type of radiation therapy requires hospitalization.

The radiation treatment for breast cancer may cause some side effects such as flushing, nausea, fatigue definition and definition. These side effects usually disappear once the treatment, although the fatigue may continue for some months. It is important that you talk to your doctor if you experience nausea or fatigue, as there is treatment in both cases (see also the guidance of symptoms that include on this website).

Radiation therapy (also known as radiation, X-ray therapy, or irradiation) uses high-energy radiation to destroy cancer cells. These rays typically comes from a machine more powerful than standard X-ray equipment used in hospitals. The X-ray beam is directed with great precision to the location of the tumor to avoid damaging effects on other body parts.

Radiation therapy is frequently administered as supportive therapy after breast cancer surgery to increase the probability to eliminate any remaining cancer cells. Support This treatment is called adjuvant radiotherapy. For example, after a definition removing only the tumor, adjuvant radiotherapy can be administered in the remaining breast tissue. In addition, radiation therapy can be administered in the thoracic region after a mastectomy definition. If the lymph nodes are not removed when performing the surgery, radiation therapy can also be given in the axillary area.

For the effective radiation treatment is necessary that the tumor receives an adequate supply of oxygen. Scientists believe that the presence of oxygen enhances the effects of radiation on tumor cells. According to some physicians, the treatment of anemia by blood transfusion or use of the hormone erythropoietin definiciónantes and during radiotherapy may increase the effectiveness of treatment.

With a perfect appearance, one can get many relations which will likely boost the possibility of making successful business. With a perfect appearance, one will be respected by the other. On the other hand, an ugly one will be despised and mocked around by the others. Thus, no matter what happen, everyone, young and old, male or female, must get the best look whenever they go out.

When old age crimples on the cheek and appear in the thigh and belly within the form of cellulite, it is better for us to search the information of how to get rid of cellulite safely. Opening some sites related to cellulite treatment is the best answer to make us able to stay young forever. The site will acknowledge us with some top rated cellulite creams accompanied by the positive and negative side effect of the cream as the barometer to find the best and safe one for us.

This has been explained to this group, consisting of 266 Spanish oncologists who have undergone study of more than 2,100 patients with lung cancer. The investigation shows that people who had EGFR gene mutation, and were treated with a specific drug, obtained a higher response rate.

This is the first large European study, which was published in The New England Journal of Medicine “and has performed in the laboratory of Molecular Biology Universiatario ICO-Hospital Germans Trias i Pujol in Badalona.

“The median survival for patients receiving the drug ‘erlotinib’ was between 14 and 27 months, almost a year longer than with traditional chemotherapy,” stated the GECP.

The gene called Factor Receptor (EGFR) is found naturally on the cell surface and its mutation occurs when there excessive activity, which can lead to uncontrolled cell division and increased predisposition to cancer.

Of the more than two thousand patients studied, the researchers found the gene mutation in 350, so that almost 16 percent of those with this disease may have this transformation.

“It should also be noted that mutations were found more frequently in women (69.7%) in non-smokers and lung tumor type called” adenocarcinoma “, explained this group of doctors.

The drug “Erlotinib is an inhibitor of EGFR gene mutation, and is currently used in patients with advanced lung cancer after first line chemotherapy, regardless of whether they have this variation.

For the director of GECP, Rafael Rosell, this discovery is “a new outlook and a new strategy in treating lung cancer,” because “patients with genetic mutations can benefit from early treatment and individualized” as well as achieve greater survival time. EFE

These carbon nanotubes with multiple layers that contain iron and are 10,000 times thinner than a human hair, described as a presentation today at the 52nd annual meeting of the American Association of Physicists in Medicine, in Philadelphia.

In the laboratory scientists Baptist Medical Center Wake Forest University (North Carolina) used a scanner for magnetic resonance imaging (MRI) to follow the trajectory of the particles inside the living tissue.

When they saw that the particles were close to a tumor they fired a laser beam and the rapid warming on that scale so small destroyed the tumor.

The method is the development of experimental technique for cancer treatment known as laser induced thermal therapy (TTIL) which uses laser energy to heat and destroy tumors.

The TTIL works because certain nanoparticles can absorb the energy of a laser and convert it into heat. If the nanoparticles are struck by lightning while inside the tumor free energy of high temperature and kill cancer cells.

But there is a problem with the TTIL: the scanner that doctors use the tumor can be clearly seen, but the particles are not seen.

Once injected into the patient they can not be traced and can be dangerous for him: if the laser reaches the particles away from the tumor when heat can destroy healthy tissue.

Hence the importance of this discovery.

The Wake Forest team has demonstrated for the first time, it is possible to make the particles visible on the MRI so as to allow the taking of the picture and simultaneous warming, according Xuanfeng Ding, who presented the study today in Philadelphia.

Because the particles are loaded with iron become visible to the scanner.

“For the treatment is very important that you can find exactly the nanoparticle inside the human body,” said Ding. “It’s really exciting to see that the tumor reached with the nanotube begins to decrease after treatment.”

If this method proves successful in the future could help people develop cancer, but still must prove that the technology is effective and safe.

The study, developed teams Ohio State University and the Research Institute Richard J. U.S. Solove, was published in the journal Cancer Prevention Reaserch.

The researchers found that the substance (indole-3-carbinol “or I3C) is related to a molecule (Cdc25A), which is essential for proliferation and cell division.

In particular, the I3C can destroy the Cdc25A, which is also a molecule that is present in high levels in breast, prostate, liver, esophagus, endometrium, and colon, and other diseases such as Alzheimer’s.

“A better understanding of this mechanism can lead to the use of a dietary supplement (of the substance) as a safe and effective strategy to treat a variety of cancers and other diseases,” said the author who led the work, Xianghong Zou.

The study, based on several experiments on breast cancer cells showed that the substance caused the destruction of the molecule, indicating the specific location that served as a target for the substance to end the molecule.

In addition, they concluded that if the location is altered by genetic mutation, IC3 can no longer destroy the molecule.

However, other tests showed that the substance itself which was reduced tumor size by 65% when administered orally to mice.

Although its use is increasingly widespread, the International Agency for Research on Cancer (IARC) has decided to raise to the maximum level the risk to human health from the use of ultraviolet light booths.

The agency has included these devices in a risk category and qualifies as “carcinogenic to humans” according to a special issue of the British journal “The Lancet Oncology.

So far, the use of these cabins was part of group 2, which called it “possibly carcinogenic“.

A group of scientists from the IARC, led by Dr. Fatiha El Ghissassi ensures that emit UV radiation that these devices involves a large risk for genetic mutation that causes melanoma, a skin tumor prognosis and accounts for 75 percent of deaths that occur each year as a result of skin cancer.

The researchers warn that, contrary to what one thinks, all UV radiation – whether UVA, UVB and UVC, are equally dangerous and add to the risk of melanoma increases by 75% when the use of cabs Ultraviolet begins before age 30.

In addition to cutaneous melanoma, IARC experts warn that seek quick tan in these devices can cause ocular tumors.

The person with anemia may feel a great tiredness and exhaustion. This is a major problem for patients with cancer and that fatigue caused by anemia does not disappear, which may make them feel very ‘discouraged’ and less able to perform their daily activities. Doctors use the name of fatigue to refer to this condition. For more information click on fatigue.

Other symptoms of anemia include:

* Dizziness and headaches
* Difficulty breathing
* Inability to concentrate
* Palpitations
* Pale lips, skin and eyes
* Loss of appetite
* Gastrointestinal disorders such as diarrhea or constipation.

Anemia can also decrease the effectiveness of cancer treatment. It is important to have a good supply of oxygen for cancer treatments such as radiotherapy and chemotherapy, to function properly. According to some scientists, the tumors are more likely to spread to other body parts when they receive an inadequate supply of oxygen. Many doctors believe it is important to treat anemia in cancer patients for cancer treatments such as radiotherapy and chemotherapy are more effective then. Click here for more information about the treatment of anemia.

Hepatocellular Carcinoma

Hepatocellular carcinoma may follow different growth patterns. Some develop growths in the form of tentacles by the liver. This pattern is most common in the United States. Others begin as a single tumor that spreads to other areas of the body at a late stage of the disease. However, other develop as nodules in different places of the liver. Sometimes the pattern is not clear.

The majority (approximately 90%) cases of primary liver cancer in adults are hepatocellular carcinomas.

Cholangiocarcinoma
(Also called bile duct cancer)

Cholangiocarcinomas grow from bile duct cells of the liver. The bile duct is a thin tube that extends from the liver to the small intestine. The bile duct starts inside the liver and several smaller tubes being joined.

Approximately 9% of cases of primary liver cancer in adults are cholangiocarcinomas. For more information, see the Guidelines for bile duct cancer (in English).

Angiosarcoma

Angiosarcoma begins in blood vessels of the liver and is growing rapidly.

Approximately 1% of cases of primary liver cancer in adults are angiosarcomas. For more information, read the Guide to the sarcoma.